470 related articles for article (PubMed ID: 29313389)
81. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
[TBL] [Abstract][Full Text] [Related]
82. Off-Label Use of Multitarget Stool DNA Testing in Primary Care.
Agarwal A; Zhang T; Ravindran N; Thuluvath PJ; Maheshwari A
Am J Gastroenterol; 2021 Apr; 116(4):829-832. PubMed ID: 33982956
[TBL] [Abstract][Full Text] [Related]
83. Lowering the colorectal cancer screening age improves predicted outcomes in a microsimulation model.
Fisher DA; Saoud L; Finney Rutten LJ; Ozbay AB; Brooks D; Limburg PJ
Curr Med Res Opin; 2021 Jun; 37(6):1005-1010. PubMed ID: 33769894
[TBL] [Abstract][Full Text] [Related]
84. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
85. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
86. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
87. Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors.
Ykema B; Rigter L; Spaander M; Moons L; Bisseling T; Aleman B; de Boer JP; Lugtenburg P; Janus C; Petersen E; Roesink J; Raemaekers J; van der Maazen R; Lansdorp-Vogelaar I; Gini A; Verbeek W; Lemmens M; Meijer G; van Leeuwen F; Snaebjornsson P; Carvalho B; van Leerdam M
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936745
[TBL] [Abstract][Full Text] [Related]
88. Use of surveillance colonoscopy in medicare patients with inflammatory bowel disease prior to colorectal cancer diagnosis.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Digestion; 2014; 90(1):58-62. PubMed ID: 25196002
[TBL] [Abstract][Full Text] [Related]
89. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
90. DNA quantification of exfoliated colonocytes as a novel screening tool for colorectal cancer.
Bajwa AA; Peck J; Loktionov A; Obichere A
Eur J Surg Oncol; 2013 Dec; 39(12):1423-7. PubMed ID: 24094980
[TBL] [Abstract][Full Text] [Related]
91. Stool test for colorectal cancer screening: what is going on?
Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
[TBL] [Abstract][Full Text] [Related]
92. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
[TBL] [Abstract][Full Text] [Related]
93. [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].
Vleggaar FP; Lutgens MW; Oldenburg B; Schipper ME; Samsom M
Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2787-91. PubMed ID: 18232199
[TBL] [Abstract][Full Text] [Related]
94. Molecular markers for colorectal cancer screening.
Dickinson BT; Kisiel J; Ahlquist DA; Grady WM
Gut; 2015 Sep; 64(9):1485-94. PubMed ID: 25994221
[TBL] [Abstract][Full Text] [Related]
95. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.
Carmona FJ; Azuara D; Berenguer-Llergo A; Fernández AF; Biondo S; de Oca J; Rodriguez-Moranta F; Salazar R; Villanueva A; Fraga MF; Guardiola J; Capellá G; Esteller M; Moreno V
Cancer Prev Res (Phila); 2013 Jul; 6(7):656-65. PubMed ID: 23694962
[TBL] [Abstract][Full Text] [Related]
96. Noninvasive fecal testing for colorectal cancer.
Zou J; Xiao Z; Wu Y; Yang J; Cui N
Clin Chim Acta; 2022 Jan; 524():123-131. PubMed ID: 34756863
[TBL] [Abstract][Full Text] [Related]
97. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
[TBL] [Abstract][Full Text] [Related]
98. [Application and prospect of fecal DNA test in colorectal cancer screening].
Ma CX; Guan X; Wang S; Liu Z; Jiang Z; Wang XS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):491-494. PubMed ID: 31104434
[TBL] [Abstract][Full Text] [Related]
99. Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening.
Yang C; Wu W; Yang Y; Yang X; Sun J; Zhang W; Liu K; Ying H; Jiang S; Yu X; Shi Y; Zhou Y; Zhu S; Xu Y; Ding Y; Xie L; Cai B; Xin X; Chen P; Zhao R; Wu Y
Oncol Lett; 2020 Aug; 20(2):1193-1200. PubMed ID: 32724359
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
